Dexmedetomidine
IGALMI is a prescription medication containing dexmedetomidine, available as a sublingual film in 120 mcg and 180 mcg doses. Manufactured by BioXcel Therapeutics, Inc., it acts as a central alpha-2 adrenergic agonist and is used for general anesthesia. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | IGALMI is a prescription medication containing dexmedetomidine, available as a sublingual film in 120 mcg and 180 mcg doses. Manufactured by BioXcel Therapeutics, Inc., it acts as a central alpha-2 adrenergic agonist and is used for general anesthesia. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Dexmedetomidine", "mediaType": "text/html", "description": " Access the FDA dataset for Dexmedetomidine — ANDA 205046 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205046" } ] |
| identifier | ANDA205046 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-information", "fda", "health-care", "prescription-drugs" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Dexmedetomidine |
